Intravenous Solutions Market

Key Highlights of the report

How are the major segments performing in the intravenous solutions market?

• In 2022, the total parenteral nutrition segment accounted for the largest market share because patients without other nutrition have a greater adoption rate. Increased cases of gastrointestinal diseases, including Ulcerative Colitis (UC) and Crohn’s Disease (CD), which impede patients from absorbing essential nutrients, are to be responsible for this.
• In 2022, the single-dose amino acids segment was anticipated to hold a prominent share in the global intravenous solutions market due to the increased use of amino acid injections, the rising prevalence of nutrient shortages and liver disorders, and other factors. The rising acceptance of improved amino acid solutions with fewer side effects drives the intravenous solutions market.
• In 2022, the hospitals and clinics segment accounted for the largest market share because there are more hospitals and clinics, and metabolic issues are more common.

What is the market size of Intravenous solutions regarding value?

The global intravenous solutions market is anticipated to grow at a substantial CAGR of 8.50% in the upcoming years. The global Intravenous solutions industry was estimated to be worth USD 11.8 billion in 2022 and was expected to be worth USD 20.9 billion by 2030.

Which region dominated the intravenous solutions market?

In 2022, the North American region was anticipated to hold a prominent share of the global intravenous solutions market. This results from the aging population, which raises the demand for intravenous solutions, the increase in chronic disease incidence, and the industry’s growth in response to the flu and coronavirus pandemics resulting in increased demand. The highly developed region of North America has a well-established healthcare system, which has increased the demand for IV therapy at different stages of its life cycle, including emergency care or surgery.

Which are the key countries in the intravenous solutions market?

In 2022, the United States is anticipated to be a leading nation in market growth. The increasing burden of diseases, the rising rate of preterm births, and the rising rate of surgeries are the main causes of this development. For instance, the second-leading cause of mortality in America, according to the Centres for Disease Control and Prevention, is cancer. In the US, cancer contributes to about one in four fatalities. In 2020, there will be around 1,806,590 new cancer cases and 606,520 fatalities in the United States, according to the American Cancer Society estimate.

In 2022, the India was anticipated to hold a prominent share in the global intravenous solutions market due to the region’s aging population and the resulting expansion of the patient pool, which has increased the volume of sales of intravenous solutions in the area. This is due to the healthcare system’s big patient population, prominent key players, simple access to drugs, well-established healthcare infrastructure, and advantageous reimbursement regulations.

How is the economy impacting the global intravenous solutions growth?

The COVID-19 pandemic outbreak has increased the market for intravenous solutions. Globally, the Intensive Care Units (ICU) are inundated by the COVID-19 patients. The multiple waves of COVID-19 strains are bringing on the increasing frequency of hospital admissions in numerous countries worldwide. Many patients, especially elderly ones, are kept on ventilators. In these circumstances, intravenous fluids are used to administer nutrition.

What is the competitive environment of the intravenous solutions market?

Market participants are introducing new intravenous injection solutions, which is anticipated to accelerate the expansion of the global intravenous solutions market throughout the forecast period. For instance, the commercial introduction of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine), which was approved by the U.S. Food and Drug Administration (FDA), was announced by Baxter International Inc. in September 2021. When an adult patient has severe, acute hypotension (low blood pressure), norepinephrine is prescribed to raise blood pressure. Baxter provides the only manufacturer-prepared ready-to-use formulation of norepinephrine, and it comes in two strengths: 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL). Similarly,  in December 2022, the medical technology business Royal Philips, which specialises in developing minimally invasive peripheral vascular devices, recently announced that it had reached a deal to buy Vesper Medical Inc. Vesper Medical will add advanced venous stents to Philips’ line of diagnostic and therapeutic devices to help treat deep venous illness. The deal is pending the usual closing requirements.

Executive Summary

What are the key trends in the Intravenous solutions market?

• Rising prevalence of chronic disorders: The market is expanding quickly as a result of the rising incidence of chronic illnesses like cancer, diabetes, and cardiovascular conditions. Many different medical disorders are treated with IV solutions, which are essential for giving patients fluids, electrolytes, and drugs. By 2045, the International Diabetes Federation (IDF) projects that 700 million individuals worldwide will have diabetes. For glucose management, diabetic patients need intravenous solutions, and during the forecast period, the demand for these solutions is anticipated to rise due to the rising prevalence of diabetes. Additionally, the market is expanding as a result of the rise in cancer cases.

How has the IV solutions market grown due to technological advancements?

One major factor driving the growth of the IV solutions market is technological advancements in IV solutions. An essential component of contemporary medical practice, IV solutions deliver medications, fluids, and nutrients straight into the bloodstream. The market is driven by the most recent technological developments in IV solutions, which have increased their effectiveness, safety, and efficiency. The creation of intelligent IV pumps is one of the most recent technological developments in the IV solution market. Intelligent IV pumps intelligently change infusion rates based on patient weight, age, and medical condition to increase patient safety and reduce medication errors. The creation of closed system transfer devices (CSTDs) is another technological development made available to consumers. As they prepare and administer intravenous therapy, healthcare professionals are protected by CSTDs from exposure to harmful medications. In cancer therapy, where harmful medications are routinely employed, CSTDs play a bigger role. Additionally, another technical development that is boosting the market internationally is the usage of nanotechnology in IV solutions.

Which are the key investments by the intravenous solutions market players?

The market for intravenous solutions is expanding due to increased investments in the nation’s healthcare infrastructure. The need for intravenous medications is anticipated to increase as more hospitals and healthcare facilities, especially those in smaller communities, become available nationwide. This is explained by the adaptability of intravenous solutions and the situations in which they are used when a patient’s nutrient and hydration absorption is insufficient.

Some major players in the intravenous solutions market are Amanta Healthcare Ltd., Axa Parenterals Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eurolife Healthcare Pvt Ltd., Fresenius Kabi AG, Grifols S.A, Henry Schein Inc., ICU Medical, Inc., JW Life Science, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc., Salius Pharma Private Limited, Sichuan Kelun Pharmaceutical Co. Ltd, Soxa Formulations & Research (Pvt.) Ltd., Vifor Pharma Management Ltd.

What are the major driving factors for the intravenous solutions market?

The rise in gastrointestinal illness and neurological ailments due to improper eating habits is a primary element driving the market’s growth rate. The key factor driving the growth rate of the intravenous (IV) solutions market is the increase in healthcare spending. The market for intravenous solutions will grow due to rising infection rates and the rising popularity of vitamin C intravenous solutions for colorectal cancer. The government’s activities and public awareness are two additional elements that will benefit the market’s growth pace. The rise in diabetes and cancer incidence is another important factor that would restrain the growth of the intravenous solutions market.

What are the Major Risks for the Intravenous solutions Market?

The high cost of the product will slow the market’s expansion. The expansion of the market for intravenous solutions will also be hampered by the regulatory authorities’ tight rules and mounting technological regulations. The market for intravenous solutions will face additional obstacles throughout the projection above period due to a lack of knowledge.

Which is the key composition in the intravenous solutions market?

The total parenteral nutrition segment is expected to hold a prominent share in the global market during the forecast period. This is a result of the prevalence of gastrointestinal conditions, including Ulcerative Colitis (UC) and Crohn’s Disease (CD), in which patients cannot absorb critical nutrients; as a result, these nutrients must be administered intravenously. The increase in the elderly population, whose patients require intravenous feeding of nutritionally vital goods, can also be attributable to the expansion.

How is the intravenous solutions market performing in regions?

Asia Pacific market is anticipated to witness the fastest growth in the global intravenous solutions market during the forecast period. The high rate of growth in this area can be attributed to the fact that both public and private organizations spend a lot of money on research, as well as on advancements in technology and an increase in partnerships between different groups of stakeholders, such as universities and the medical community. Additional important factors anticipated to fuel market growth in the Asia Pacific region include the rising prevalence of chronic diseases brought on by bad eating habits and the rising desire for cost-effective treatments.

What is the regulatory landscape for the intravenous solutions market?

To ensure patient safety, the manufacture, distribution, and use of intravenous solutions are subject to quality standards set by the U.S. Food and Drug Administration. Producers of medical equipment, such as infusion pumps, must adhere to the EU Medical Device Regulation (MDR) to further secure the quality of their products and the safety of their customers.

What are the major players planning for the future of the intravenous solutions market?

The development of fresh technologies that make intravenous administration safer and more efficient is anticipated to fuel market revenue growth in coming years. For instance, smart pumps are becoming increasingly commonplace on the market since they can automatically change the rate of infusion based on the patient’s condition and the type of drug being administered. These pumps are designed to increase patient outcomes and reduce the likelihood of drug errors.

Segmentation of Global Intravenous Solutions Market-

Global Intravenous Solutions Market – By Type

• Partial Parenteral Nutrition
• Total Parenteral Nutrition

Global Intravenous Solutions Market – By Composition

• Carbohydrates
• Vitamins and Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others

Global Intravenous Solutions Market – By End Users

• Hospitals and Clinics
• Ambulatory Surgery Centers
• Home care settings

Global Intravenous Solutions Market – By Region

• North America
  • U.S
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Intravenous Solutions Market
2.2. Global Intravenous Solutions Market, By Type
2.3. Global Intravenous Solutions Market, By Composition
2.4. Global Intravenous Solutions Market, By End Users
2.5. Global Intravenous Solutions Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Intravenous Solutions Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Composition
3.5.3. End Users
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Intravenous Solutions Market, By Type
7.1. Global Intravenous Solutions Market Overview, by Type
7.1.1. Global Intravenous Solutions Market Revenue Share, By Type, 2022 Vs 2030 (in %)
7.2. Partial Parenteral Nutrition
7.2.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
7.3. Total Parenteral Nutrition
7.3.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)

8. Global Intravenous Solutions Market, By Composition
8.1. Global Intravenous Solutions Market Overview, by Composition
8.1.1. Global Intravenous Solutions Market, By Composition, 2022 vs 2030 (in %)
8.2. Carbohydrates
8.2.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
8.3. Vitamins and Minerals
8.3.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
8.4. Single Dose Amino Acids
8.4.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
8.5. Parenteral Lipid Emulsion
8.5.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
8.6. Others
8.6.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)

9. Global Intravenous Solutions Market, by End Users, 2017-2030 (US$ Bn)
9.1. Global Intravenous Solutions Market Overview, by End Users
9.1.1. Global Intravenous Solutions Market, By End Users, 2022 vs 2030 (in%)
9.2. Hospitals and Clinics
9.2.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
9.3. Ambulatory Surgery Centers
9.3.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)
9.4. Home Care Settings
9.4.1. Global Intravenous Solutions Market, By Region, 2017-2030 (US$ Bn)

10. Global Intravenous Solutions Market, By Region
10.1. Global Intravenous Solutions Market Overview, by Region
10.1.1. Global Intravenous Solutions Market, By Region, 2022 vs 2030 (in%)
10.2. Type
10.2.1. Global Intravenous Solutions Market, By Type, 2017-2030 (US$ Bn)
10.3. Composition
10.3.1. Global Intravenous Solutions Market, By Composition, 2017-2030 (US$ Bn)
10.4. End Users
10.4.1. Global Intravenous Solutions Market, By End Users, 2017-2030 (US$ Bn)

11. North America Intravenous Solutions Market Analysis
11.1. North America Intravenous Solutions Market, by Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Intravenous Solutions Market, by Composition, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Intravenous Solutions Market, by End Users, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Intravenous Solutions Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Intravenous Solutions Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
11.4.3.3. Canada Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
11.4.3.4. Canada Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)

12. Europe Intravenous Solutions Market Analysis
12.1. Europe Intravenous Solutions Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Intravenous Solutions Market, by Composition, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Intravenous Solutions Market, by End Users, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Intravenous Solutions Market, by Country, 2017-2030 (US$ Bn)
12.4.1. Europe Intravenous Solutions Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
12.4.2.3. Germany Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
12.4.2.4. Germany Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
12.4.3.3. France Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
12.4.3.4. France Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
12.4.4.3. UK Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
12.4.4.4. UK Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
12.4.5.3. Italy Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
12.4.5.4. Italy Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
12.4.6.3. Spain Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
12.4.6.4. Spain Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)

13. Asia Pacific Intravenous Solutions Market Analysis
13.1. Asia Pacific Intravenous Solutions Market, by Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Intravenous Solutions Market, by Composition, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Intravenous Solutions Market, by End Users, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Intravenous Solutions Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Intravenous Solutions Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
13.4.2.3. China Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
13.4.2.4. China Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
13.4.3.3. Japan Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
13.4.3.4. Japan Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
13.4.4.3. India Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
13.4.4.4. India Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)

14. Latin America Intravenous Solutions Market Analysis
14.1. Latin America Intravenous Solutions Market, by Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Intravenous Solutions Market, by Composition, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Intravenous Solutions Market, by End Users, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Intravenous Solutions Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Intravenous Solutions Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)

15. Middle East and Africa Intravenous Solutions Market Analysis
15.1. Middle East and Africa Intravenous Solutions Market, by Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Intravenous Solutions Market, by Composition, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Intravenous Solutions Market, by End Users, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Intravenous Solutions Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Intravenous Solutions Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Intravenous Solutions Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Intravenous Solutions, By Type, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Intravenous Solutions, By Composition, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Intravenous Solutions, By End Users, 2017-2030 (US$ Bn)

16. Company Profiles
16.1. Amanta Healthcare Ltd.
16.1.1. Company Overview
16.1.2. Products/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. Axa Parenterals Ltd
16.3. B. Braun Melsungen AG
16.4. Baxter International Inc.
16.5. Becton
16.6. Dickinson and Company
16.7. Eurolife Healthcare Pvt Ltd.
16.8. Fresenius Kabi AG
16.9. Grifols S.A
16.10. Henry Schein Inc.
16.11. ICU Medical, Inc.
16.12. JW Life Science,
16.13. Otsuka Pharmaceutical Co., Ltd.
16.14. Pfizer, Inc.
16.15. Salius Pharma Private Limited
16.16. Sichuan Kelun Pharmaceutical Co. Ltd
16.17. Soxa Formulations & Research (Pvt.) Ltd
16.18. Vifor Pharma Management Ltd

List of Figures
FIG. 1 Global Intravenous Solutions Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Intravenous Solutions Market Segmentation
FIG. 4 Global Intravenous Solutions Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Intravenous Solutions Market, by Composition, 2022 (US$ Bn)
FIG. 6 Global Intravenous Solutions Market, by End Users, 2022 (US$ Bn)
FIG. 7 Global Intravenous Solutions Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Type, 2022
FIG. 9 Attractive Investment Proposition, by Composition, 2022
FIG. 10 Attractive Investment Proposition, by End Users, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Intravenous Solutions Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Intravenous Solutions Market Manufacturers, 2022
FIG. 14 Global Intravenous Solutions Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 15 Global Intravenous Solutions Market, by Partial Parenteral Nutrition, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Intravenous Solutions Market, by Total Parenteral Nutrition, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Intravenous Solutions Market Value Contribution, By Composition, 2022 & 2030 (Value %)
FIG. 18 Global Intravenous Solutions Market, by Carbohydrates, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Intravenous Solutions Market, by Vitamins and Minerals, 2017-2030 (US$ Bn)
FIG. 20 Global Intravenous Solutions Market, by Single Dose Amino Acids, 2017-2030 (US$ Bn)
FIG. 21 Global Intravenous Solutions Market, by Parenteral Lipid Emulsion, 2017-2030 (US$ Bn)
FIG. 22 Global Intravenous Solutions Market, by Others, 2017-2030 (US$ Bn)
FIG. 23 Global Intravenous Solutions Market Value Contribution, By End Users, 2022 & 2030 (Value %)
FIG. 24 Global Intravenous Solutions Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Intravenous Solutions Market, by Ambulatory Surgery Centers, 2017-2030 (US$ Bn)
FIG. 26 Global Intravenous Solutions Market, by Home Care Settings, 2017-2030 (US$ Bn)
FIG. 27 North America Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 28 U.S. Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 29 Canada Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 30 Europe Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 31 Germany Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 32 France Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 33 U.K. Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 34 Italy Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 35 Spain Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 36 Rest of Europe Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 37 Asia Pacific Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 38 China Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 39 Japan Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 40 India Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 41 South Korea Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 42 South-East Asia Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 43 Rest of Asia Pacific Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 44 Latin America Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 45 Brazil Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 46 Mexico Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 47 Rest of Latin America Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 48 Middle East & Africa Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 49 GCC Countries Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 50 South Africa Intravenous Solutions Market, 2017-2030 (US$ Bn)
FIG. 51 Rest of Middle East and Africa Intravenous Solutions Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Intravenous Solutions Market
TABLE 2 Global Intravenous Solutions Market: Market Drivers Impact Analysis
TABLE 3 Global Intravenous Solutions Market: Market Restraints Impact Analysis
TABLE 4 Global Intravenous Solutions Market, by Competitive Benchmarking, 2022
TABLE 5 Global Intravenous Solutions Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Intravenous Solutions Market, by Key Strategies Analysis, 2022
TABLE 7 Global Intravenous Solutions Market, by Partial Parenteral Nutrition, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Intravenous Solutions Market, by Partial Parenteral Nutrition, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Intravenous Solutions Market, by Total Parenteral Nutrition, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Intravenous Solutions Market, by Total Parenteral Nutrition, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Intravenous Solutions Market, by Carbohydrates, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Intravenous Solutions Market, by Carbohydrates, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Intravenous Solutions Market, by Vitamins and Minerals, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Intravenous Solutions Market, by Vitamins and Minerals, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Intravenous Solutions Market, by Single Dose Amino Acids, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Intravenous Solutions Market, by Single Dose Amino Acids, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Intravenous Solutions Market, by Parenteral Lipid Emulsion, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Intravenous Solutions Market, by Parenteral Lipid Emulsion, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Intravenous Solutions Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Intravenous Solutions Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Intravenous Solutions Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Intravenous Solutions Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Intravenous Solutions Market, by Ambulatory Surgery Centers, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Intravenous Solutions Market, by Ambulatory Surgery Centers, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Intravenous Solutions Market, by Home Care Settings, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Intravenous Solutions Market, by Home Care Settings, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 28 Global Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 29 Global Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 30 Global Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 31 Global Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 32 Global Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 33 Global Intravenous Solutions Market, by Region, 2017-2022 (US$ Bn)
TABLE 34 Global Intravenous Solutions Market, by Region, 2023-2030 (US$ Bn)
TABLE 35 North America Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 36 North America Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 37 North America Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 38 North America Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 39 North America Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 40 North America Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 41 North America Intravenous Solutions Market, by Country, 2017-2022 (US$ Bn)
TABLE 42 North America Intravenous Solutions Market, by Country, 2023-2030 (US$ Bn)
TABLE 43 United States Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 44 United States Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 45 United States Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 46 United States Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 47 United States Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 48 United States Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 49 Canada Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 50 Canada Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 51 Canada Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 52 Canada Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 53 Canada Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 54 Canada Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 55 Mexico Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 56 Mexico Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 57 Mexico Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 58 Mexico Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 59 Mexico Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 60 Mexico Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 61 Europe Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 62 Europe Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 63 Europe Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 64 Europe Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 65 Europe Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 66 Europe Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 67 Europe Intravenous Solutions Market, by Country, 2017-2022 (US$ Bn)
TABLE 68 Europe Intravenous Solutions Market, by Country, 2023-2030 (US$ Bn)
TABLE 69 Germany Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 70 Germany Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 71 Germany Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 72 Germany Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 73 Germany Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 74 Germany Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 75 France Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 76 France Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 77 France Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 78 France Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 79 France Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 80 France Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 81 United Kingdom Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 82 United Kingdom Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 83 United Kingdom Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 84 United Kingdom Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 85 United Kingdom Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 86 United Kingdom Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 87 Italy Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 88 Italy Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 89 Italy Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 90 Italy Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 91 Italy Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 92 Italy Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 93 Spain Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 94 Spain Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 95 Spain Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 96 Spain Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 97 Spain Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 98 Spain Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 99 Rest of Europe Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 100 Rest of Europe Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 101 Rest of Europe Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 102 Rest of Europe Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 103 Rest of Europe Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 104 Rest of Europe Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 105 Asia Pacific Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 106 Asia Pacific Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 107 Asia Pacific Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 108 Asia Pacific Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 109 Asia Pacific Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 110 Asia Pacific Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 111 China Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 112 China Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 113 China Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 114 China Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 115 China Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 116 China Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 117 Japan Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 118 Japan Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 119 Japan Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 120 Japan Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 121 Japan Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 122 Japan Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 123 India Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 124 India Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 125 India Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 126 India Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 127 India Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 128 India Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 129 South Korea Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 130 South Korea Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 131 South Korea Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 132 South Korea Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 133 South Korea Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 134 South Korea Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 135 South-East Asia Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 136 South-East Asia Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 137 South-East Asia Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 138 South-East Asia Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 139 South-East Asia Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 140 South-East Asia Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 141 Rest of Asia Pacific Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 142 Rest of Asia Pacific Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 143 Rest of Asia Pacific Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 144 Rest of Asia Pacific Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 145 Rest of Asia Pacific Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 146 Rest of Asia Pacific Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 147 Latin America Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 148 Latin America Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 149 Latin America Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 150 Latin America Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 151 Latin America Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 152 Latin America Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 153 Brazil Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 154 Brazil Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 155 Brazil Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 156 Brazil Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 157 Brazil Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 158 Brazil Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 159 Argentina Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 160 Argentina Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 161 Argentina Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 162 Argentina Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 163 Argentina Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 164 Argentina Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 165 Rest of Latin America Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 166 Rest of Latin America Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 167 Rest of Latin America Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 168 Rest of Latin America Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 169 Rest of Latin America Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 170 Rest of Latin America Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 171 Middle East and Africa Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 172 Middle East and Africa Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 173 Middle East and Africa Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 174 Middle East and Africa Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 175 Middle East and Africa Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 176 Middle East and Africa Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 177 GCC Countries Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 178 GCC Countries Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 179 GCC Countries Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 180 GCC Countries Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 181 GCC Countries Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 182 GCC Countries Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 183 South Africa Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 184 South Africa Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 185 South Africa Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 186 South Africa Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 187 South Africa Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 188 South Africa Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)
TABLE 189 Rest of Middle East and Africa Intravenous Solutions Market, by Type, 2017-2022 (US$ Bn)
TABLE 190 Rest of Middle East and Africa Intravenous Solutions Market, by Type, 2023-2030 (US$ Bn)
TABLE 191 Rest of Middle East and Africa Intravenous Solutions Market, by Composition, 2017-2022 (US$ Bn)
TABLE 192 Rest of Middle East and Africa Intravenous Solutions Market, by Composition, 2023-2030 (US$ Bn)
TABLE 193 Rest of Middle East and Africa Intravenous Solutions Market, by End Users, 2017-2022 (US$ Bn)
TABLE 194 Rest of Middle East and Africa Intravenous Solutions Market, by End Users, 2023-2030 (US$ Bn)